COPD Flashcards

1
Q

Cardinal symptoms that would raise suspicion for COPD

A

Cardinal symptoms: SOB and activity limitation

SOB is persistent, progressive, worse with exercise

Other symptoms: persistent cough, sputum production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Symptoms of AECOPD

A

Sustained (>48 hours) worsening SOB and cough beyond day-to-day variance with increased sputum volume with purulence –> leads to increase in maintenance meds and/or additional meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

two most common conditions that contribute to COPD?

A

emphysema (destruction of alveoli)

chronic bronchitis (chronic inflammation of bronchioles)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the major comorbidities leading to hospitalizations and morbidity/mortality in COPD?

A

mild to moderate: cardiovascular disease is leading cause of hospitalization

severe: resp failure and pneumonia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

When should a diagnosis of COPD be considered?

A

Pt is 40 and older with:

  • dyspnea: progressive, persistent and worse with exercise
  • chronic cough AND
  • increased sputum production

AND

one of following:

  • hx of exposure to cigarette smoke
  • hx of environmental/occupational exposure to smoke, dust, gas/fumes
  • frequent res infections OR
  • family hx of COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What will CXR show in COPD?

A

hyperinflation (air trapping)

not used in diagnosis but can determine or rule out other comorbidities (eg HF, TB, pneumonia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Lung function between symptoms will show ______ in COPD

A

persistent air flow limitation

FEV1 may improve with therapy but post-bronchodilator FEV1/FVC <0.7 persists

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

COPD severity is determined by:

A
  • current level of symptoms (dyspnea scale)
  • spirometry (FEV1)
  • health status (COPD assessment tool)
  • risk of exacerbation
  • comorbidities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

5 A’s for smoking cessation

A
ask at every visit
advise
assess readiness 
assist with quitting
arrange f/u
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Components of Lifestyle and Self Management of COPD

  • smoking
  • physical activity
  • diet
  • pulmonary rehab
  • air quality
A
  • smoking: quit
  • physical activity: stay active despite symptoms of dyspnea
  • diet: maintain BMI 20-25 (low weight and anorexia is risk factor for COPD progression)
  • air quality: stay indoors when poor
  • pulmonary rehab is moderate to severe COPD
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Immunizations recommended in COPD

A
annual flu vaccine
COVID
pneumococcal polysaccharide
Tdap (if not received in adolescence)
shingles
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Management of AECOPD

3 components

A
  • short acting bronchodilator
  • salbutamol 400-800 mcg MDI
  • po prednisone
  • 40-50 mg x 5 days
  • no tapering needed
  • not to exceed 5 days
  • antibiotics
  • if symptoms and risk factors for bacterial infection
  • 5-7 days
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Treatment of COPD

Step 1 first line treatment for short term relief of SOB

A

Step 1: SAMA or SABA for acute short term relief of SOB
• Moderate to severe COPD: SAMA or SABA monotherapy recommended
○ SAMA may reduce risk of AECOPD and improve QoL
If not well controlled on monotherapy, try combo SABA + SABA

SAMA = ipratropium (atrovent)
SABA = salbutamol (ventolin)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Treatment of COPD

Step 2 for symptom relief and prevent exacerbations

A

Add LAMA or LABA

LAMA preferred
(tiotropium = Spiriva)

if monotherapy does not control, can try LAMA + LABA combo
(tiotropium + oladaterol = Inspiolto Respimat)

*do not use SAMA and LAMA together (two muscarinic antagonists)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Treatment of COPD

Step 3: to prevent exacerbations

A

Step 3: Triple therapy of LABA + ICS and LAMA to prevent exacerbations
• Moderate to severe COPD and repeated exacerbations (<50% predicted and 2+ exacerbations in last 12 months)

ICS + LABA = fluticasone + salmeterol (Advair)
Budesonide + formeterol (Symbicort)
Fluticasone + vilanterol (Breo ellipta)

Do not use ICS monotherapy in COPD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Acute exacerbation of COPD

6 possible differential diagnoses

A
pneumonia
pneumothorax
pleural effusion
pulmonary embolism
pulmonary edema
cardiac arrhythmias (Afib/flutter)
17
Q

COPD

6 possible differential diagnoses

A
  • asthma
  • CHF
  • bronchiectasis
  • TB
  • obliterative bronchiolitis
  • diffuse panbronchiolitis
18
Q

COPD

use of ICS

A

monotherapy not recommended

associated with increased risk of pneumonia especially at high doses

used in combo with LABA
eg advair (fluticasone + salmeterol)
Breo Ellipta (fluticasone + vilanterol)
Symbicort (budesonide + formeterol)

19
Q

COPD

use of azithro

  • indication
  • dose
  • side effects
  • caution
A

Azithromycin: macrolides have anti-inflammatory properties
maintenance dose to reduce risk of AECOPD
• 250 mg daily or 250 mg 3x/week
• Side effects: QT prolongation, hearing, nasopharyngeal colonization with macrolide resistant bacteria
Caution: fatal cardiac arrhythmias (eg long QT, lyte imbalance, arrhythmia, cardiac insufficiency, concurrent long QT meds, elderly)

20
Q

COPD

first line antibiotic treatment for AECOPD if < 4 exacerbations/year

duration?
sign of first line failure?

A

amoxil 1 g po TID

OR

doxy 200 mg x 1 then 100 mg BID

OR

septra DS BID

Duration: 5-7 days
Sign of failure: no improvement after finishing or worst after 72 hours

21
Q

COPD

antibiotic treatment for AECOPD if 4 or more exacerbations per year
OR 
failure of first line
OR 
antibiotics in last 3 months
A

amox-clav BID x 5-10 days

OR

cefuroxime BID x 5-10 days

OR

levofloxacin OD x 5 days (only if beta-lactam allergic or failure to first line)

*if failure of first line: use different antibiotic class

Azithro and Clarithromycin (macrolides):
*poor Haemophilus coverage and S pneumoniae resistance

22
Q

SAMA

  • example
  • indication
  • side effects
  • caution
A

SAMA
Regular Pharmacare
• Ipratropium (Atrovent)

Indication: short term symptom relief (step one)

Side effects: headache, dry mouth, cough, throat irritation, metallic taste

Caution: risk urinary retention (eg BPH), narrow angle glaucoma

23
Q

SABA

  • example
  • indication
  • side effects
  • caution
A

SABA
Regular Pharmacare except ventolin diskus
• Salbutamol (Ventolin MDI or diskus, Airomir MDI)
• Terbutaline (bricanyl turbuhaler)

Indication: for short term symptom relief (step one)

Side effects: tremor, tachycardia, restlessness, headache, muscle craps

Caution: cardiovascular d/o (CAD, arrhythmias, HTN)

24
Q

LAMA

  • example
  • indication
  • side effects
  • caution
  • teaching
A

LAMA
Incruse and Spiriva Respimat covered under regular benefit
SA for others if failed trial of Incruse / Spiriva Respimat
No product is superior: consider usability and adherence

* Umeclidinium (Incruse Ellipta)
* Tiotropium (Spiriva Respimat or Handihaler)
* Glycopydrronium (Seebri Breezhaler)
* Aclidinium (Tudorza Genuair)

Indication: symptom relief and prevent exacerbation (step 2)

Side effects: headache, dry mouth, urinary retention, metallic taste

Caution: existing urinary obstruction (eg BPH), narrow angle glaucoma

Teaching: rinse mouth, avoid spraying to eyes

25
Q

LABA

  • example
  • indication
  • side effects
  • caution
  • teaching
A
LABA -"erol"
SA except formeterol (non-benefit)
	• Formeterol (Foradil Aerolizer)
	• Indacaterol (Onbrez Breezhaler)
	• Salmeterol  (Serevent Diskus)
	• Oladaterol  (Striverdi Respimat)

Indication: symptom relief and prevent exacerbations (step 2)

Side effects: cough, headache, palpitations, tachycardia, muscle spasms, URTI

Caution: cardiovascular disorder (eg coronary insufficiency, arrhythmias, HTN)
○ Watch hyperglycemia if diabetic

Teaching: not for rescue use. Use SABA PRN for acute dyspnea

26
Q

ICS + LABA

  • example
  • indication
  • side effects
  • teaching
A

ICS and LABA
SA for all
Symbicort is non-benefit for COPD, SA if asthma

* Fluticasone + salmeterol (Advair Diskus)
* Fluticasone + vilanterol (Breo Ellipta)
* Budesonide + formeterol (Symbicort turbuhaler)

Indication: moderate to severe COPD with repeated exacerbations, to prevent exacerbations (Step 3)

Side effects: palpitations, thrush, headache, tremor, irritation, coughing

Teaching: rinse mouth and throat after each use, clean dentures

27
Q

LAMA + LABA combo

  • example
  • indication
  • side effects
  • combo
  • teaching
A

LAMA + LABA combo
SA coverage for all
Regular use

* Tiotropium + olodaterol (Inspiolto Respimat)
* Umeclidinium + vilanterol (Anoro Ellipta)
* Aclidinium + formoterol (Duaklir)
* Glycopyrronium + indacaterol (Ultibro Breezhaler)

Indication: if not controlled monotherapy LAMA or LABA

Side effects: irritation, cough, URTI, tooth abscess, headache, tremor, dry mouth

Caution: cardiovascular disorder (eg coronary insufficiency, arrhythmias, HTN), existing urinary obstruction (eg BPH), narrow angle glaucom
Watch hyperglycemia if diabetic

Teaching: rinse mouth

28
Q

SAMA + SABA combo

  • example
  • indication
  • side effects
  • caution
A

Ipratropium and salbutamol (Combivent Respimat)

Indication: if not well controlled monotherapy SABA or SAMA

Side effects: headache, dry mouth, cough, throat irritation, metallic taste, tremor, tachycardia, restlessness, headache, muscle craps

Caution: risk urinary retention (eg BPH), narrow angle glaucoma, cardiovascular d/o (CAD, arrhythmias, HTN)